Effect of a clown's presence at botulinum toxin injections in children: a randomized, prospective study

Lars Kjaersgaard Hansen1, Maria Kibaek, Torben Martinussen

  • 1Department of Paediatrics, Hans Christian Andersen Children's Hospital, Odense University Hospital, Odense.

Journal of Pain Research
|October 18, 2011
PubMed

Insights

Hospital clowns reduced crying in girls during repeat botulinum toxin treatments, but not in first-time patients or young boys. The study evaluated clown presence during painful pediatric procedures.

Area of Science:

  • Pediatric medicine
  • Child psychology
  • Pain management

Background:

  • Hospital clown interventions are rarely studied in pediatric procedures.
  • Botulinum toxin injections are painful and stressful for children.
  • This study assessed hospital clown impact on pediatric botulinum toxin treatments.

Purpose of the Study:

  • To evaluate the effect of a hospital clown's presence on children undergoing botulinum toxin injections.
  • To determine if clown presence influences the duration of crying during the procedure.

Main Methods:

  • 121 botulinum toxin treatment sessions were prospectively enrolled over 2 years.
  • Children were randomized to receive treatment with or without a hospital clown.
  • The primary outcome measure was the duration of crying during the procedure.

Main Results:

  • Clown presence significantly reduced crying duration in girls.
  • Younger boys (under 8) experienced increased crying with a clown present.
  • No significant effect was observed for children undergoing their first treatment.

Conclusions:

  • Hospital clowns did not benefit children receiving their first botulinum toxin treatment.
  • Repeat treatments showed a positive effect for girls but a negative effect for boys under 8.
  • Gender and prior treatment experience influence the effectiveness of hospital clowns in pediatric pain management.
Abstract

Related Concept Videos

Botulism01:22

Botulism

Botulism is a life-threatening neuroparalytic condition caused by botulinum neurotoxin, which is produced by the bacterium Clostridium botulinum, a Gram-positive, spore-forming, obligate anaerobe.In adults, the toxin enters the body in different ways: in foodborne botulism, the preformed toxin is absorbed in the intestine. In wound botulism, spores grow in injured tissue and release the toxin into the blood. Infant botulism differs mechanistically from adult forms. In infants, botulism commonly...
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin01:26

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
Depolarizing Blockers: Pharmocokinetics01:19

Depolarizing Blockers: Pharmocokinetics

Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
Blinding01:11

Blinding

Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...